Status:
UNKNOWN
Paediatric European Group A Streptococcal United Study.
Lead Sponsor:
Noordwest Ziekenhuisgroep
Collaborating Sponsors:
European Society for Paediatric Infectious Diseases
Medical University of Graz
Conditions:
Invasive Group A Beta-Haemolytic Streptococcal Disease
Eligibility:
All Genders
Up to 18 years
Brief Summary
Introduction Since 2022 there are reports of a rapid increase in invasive group A streptococcal infections (iGAS) in children in some but not all European countries. Detailed information on this incre...
Eligibility Criteria
Inclusion
- All children (1 month-18 years)
- attending the Emergency Department and/or admitted to the participating hospital - with iGAS infection or other invasive or emergent infectious disease.
Exclusion
Key Trial Info
Start Date :
September 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06058117
Start Date
September 20 2023
End Date
December 1 2025
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Noordwest Ziekenhuisgroep
Alkmaar, North Holland, Netherlands, 1815 JD